Association between hormonal genetic polymorphisms and early-onset prostate cancer (Q45265466)

11 December 2017

Association between hormonal genetic polymorphisms and early-onset prostate cancer (English)

1 reference

11 December 2017

1 reference

3

1 reference

11 December 2017

14

1 reference

11 December 2017

D T Bishop

13

0 references

Richard A Oram

object named as

R Oram

12

0 references

Zsofia Kote-Jarai

4

object named as

Z Kote-Jarai

1 reference

11 December 2017

M S Forrest

1

1 reference

11 December 2017

S M Edwards

2

1 reference

11 December 2017

T Key

5

1 reference

11 December 2017

N Allen

6

1 reference

11 December 2017

M A Knowles

7

1 reference

11 December 2017

F Turner

8

1 reference

11 December 2017

A Ardern-Jones

9

1 reference

11 December 2017

A Murkin

10

1 reference

11 December 2017

S Williams

11

1 reference

11 December 2017

CR-UK/BPG UK prostate cancer study collaborators

15

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

Prostate Cancer and Prostatic Diseases

11 December 2017

1 reference

11 December 2017

8

1 reference

11 December 2017

1

1 reference

11 December 2017

95-102

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.pcan.4500785

11 December 2017

0 references

cites work

Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

21 January 2018

Cancer statistics, 1994.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

Family history and the risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

Familial patterns of prostate cancer: a case-control analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

Cloning and sequence of the human gene for P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase): similarity with the gene for P450c21

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

PNU 157706, a novel dual type I and II 5alpha-reductase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

The CAG repeat within the androgen receptor gene and its relationship to prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

A polymorphism in the CYP17 gene is associated with prostate cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

Evidence for an association between the SRD5A2 (type II steroid 5 alpha-reductase) locus and prostate cancer in Italian patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

5alpha-reductase 2 polymorphisms as risk factors in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type II

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

Prediction of bone density from vitamin D receptor alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

A case-control study of diet and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

Prognostic factors in survival free of progression after androgen deprivation therapy for treatment of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

The influence of finasteride on the development of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

Serum androgen levels in men: impact of health status and age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

Vitamin D receptor polymorphisms as markers in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

Genetic predisposition to prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

Prevalence of the APC E1317Q variant in colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

Links between genetic and environmental factors and prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

7 January 2021

Androgen receptor polymorphisms: Association with prostate cancer risk, relapse and overall survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

7 January 2021

Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

7 January 2021

Unusual length polymorphism in human steroid 5 alpha-reductase type 2 gene (SRD5A2)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

7 January 2021

Monte Carlo tests for associations between disease and alleles at highly polymorphic loci

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

7 January 2021

The androgen receptor exon 1 trinucleotide repeat does not act as a modifier of the age of presentation in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500785

7 January 2021

Identifiers

DOI

10.1038/SJ.PCAN.4500785

1 reference

Dimensions Publication ID

11 December 2017

0 references

1 reference